Fennec Provides Corporate Update and Announces Fiscal Year Ended December 31, 2015 Financial Results
RESEARCH TRIANGLE PARK, NORTH CAROLINA -- (Marketwired) -- 03/28/16 -- Fennec Pharmaceuticals Inc. (TSX: FRX)(OTCQB: FENCF), a specialty pharmaceutical company focused on the development of Sodium Thiosulfate (STS) for the prevention of platinum-induced …